Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma
Conditions:   B-cell Acute Lymphoblastic Leukemia;   Lymphoblastic B-Cell Lymphoma Interventions:   Biological: CD19 CAR-T-cells;   Drug: Tocilizumab Sponsor:   Belarusian Research Center for Pediatric Oncology, Hematology and Immunology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2022 Category: Research Source Type: clinical trials

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Condition:   Non-Hodgkin Lymphoma, Follicular Lymphoma Interventions:   Drug: Mosunetuzumab SC;   Drug: Tiragolumab;   Drug: Atezolizumab;   Other: Tocilizumab Sponsor:   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2022 Category: Research Source Type: clinical trials